R. W. Dal Negro (Verona, Italy), R. Dahl (Aarhus, Denmark)
Comparison of residual eosinophilic inflammation in the distal airway of patients with well-controlled asthma using different drug combinations of asthma treatment
H. Ohbayashi (Gifu, Japan)
|  |
Oxidative stress and inhaled steroids in stable chronic obstructive pulmonary disease
O. Lorenzo, J. Abreu, C. Hernández, P. Abreu-González, N. Lorenzo (La Laguna, La Laguna, Tenerife, Spain)
| |
Long-term use of antioxidant mucolytic erdosteine is especially beneficial in patients with more severe COPD
M. Ballabio, M. Nicola, M. Moretti (Milano, Modena, Italy)
|  |
Duration of systemic corticosteroids treatment in COPD exacerbations
M. Gomaa, M. Faramawy, H. Ibrahim (Cairo, Egypt)
| |
What is the best method for investigating the impact of tiotropium on hyperinflation in COPD?
G. Curradi, A. Segreti, M. Mura, C. Ciaprini, L. Senis, C. Saltini, M. Cazzola (Rome, Italy)
| |
Oral immunotherapy in preventing exacerbations of COPD
N. N. Shah, R. Bhargava, Z. Ahmed, M. Shameem, K. A. Dar, Q. Syed, M. M. Mirza, A. A. Bachh (Srinagar, J&K, Aligarh, Uttar Pradesh, India)
| |
Annual decline in forced expiratory volume in 1 sec (FEV1) in patients with COPD before and after introduction of tiotropium
S. Fuke, H. Makita, M. Hasegawa, Y. Nasuhara, T. Betsuyaku, M. Nishimura (Sapporo, Japan)
| |
Erythromycin restores HDAC2 levels diminished under oxidative and inflammatory stress in vitro and in vivo
K. Ito, C. Charron, C. Wiegman, P. Barnes (London, United Kingdom)
| |
Dose-ranging study to assess the efficacy and tolerability of NVA237, a once daily long-acting muscarinic antagonist, in patients with COPD
T. Overend, Y. Fukuchi, A. Flemale, C. Verkindre, A. Takeda, J. Johnson, N. Prasad, G. Geba (West Sussex, United Kingdom; Tokyo, Hokkaido, Japan; Bruxelles, Belgium; Beuvry, France; New Jersey, United States Of America)
| |
Low systemic exposure to aclidinium bromide, a novel long-acting anticholinergic, after multiple doses
G. de Miquel, A. Schrodter, B. Miletzki, M. Gurniak, R. Lamarca, J. Jansat (Barcelona, Spain; Neuss, Tubingen, Germany)
| |
Tiotropium reduces the risk of exacerbations irrespective of previous use of inhaled anticholinergics in placebo-controlled clinical trials
C. Cooper, M. Decramer, I. Leimer, S. Kesten (Los Angeles, CA, United States Of America; Leuven, Belgium; Ingelheim, Germany)
| |
24-hour bronchodilator efficacy of single doses of indacaterol in subjects with COPD, and comparison with formoterol
V. Ninane, E. Derom, J. B. Martinot, M. Higgins, R. Firth, R. Owen, F. Dong (Bruxelles, Gent, Namur, Belgium; West Sussex, United Kingdom; New Jersey, United States Of America)
| |
Budesonide/formoterol for the treatment of COPD exacerbations in the primary healthcare setting
B. Ställberg, E. B. C. Andersson, T. Ekström, O. Selroos, C. Vogelmeier, K. Larsson (Uppsala, Södertälje, Lund, Stockholm, Sweden; Marburg, Germany)
| |
Cardiac safety of indacaterol, a novel once-daily bronchodilator, in COPD
J. Beier, T. Bantje, R. Owen, D. Jack, L. Brookman, M. Higgins (Wiesbaden, Germany; Breda, Netherlands; West Sussex, United Kingdom)
| |
Improvement in quality of life with tiotropium in smokers and quitters with COPD
T. Glaab, N. Metzdorf, K. Wolf, H. Rau-Berger (Ingelheim, Germany)
| |
Peak inspiratory flow in patients with moderate or severe COPD using the Almirall inhaler
H. Magnussen, H. Watz, I. Zimmermann, S. Macht, R. Greguletz, D. Jarreta, E. Garcia Gil (Grosshansdorf, Bad Homberg, Germany; Barcelona, Spain)
| |
The impact of insulin-sensitizers on lung function in COPD
Y. S. Shim, C. H. Lee, J. J. Yim, S. C. Yang, C. G. Yoo, H. S. Chung, Y. W. Kim, S. K. Han (Seoul, Republic Of Korea)
| |
Tiotropium bromide reduces PMN chemotaxis induced by alveolar macrophages of COPD patients
G. Vacca, K. Dück, R. Dück, M. Pieper, A. Gillissen (Leipzig, Biberach an der Riß, Germany)
| |
Effect of once-daily inhaled glucocorticosteroid administration on exhaled nitric oxide in controlled asthma patients
M. Karayama, N. Inui, Y. Suzuki, T. Suda, K. Chida (Hamamatsu, Japan)
| |